{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:04:08Z","timestamp":1792476248032,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jtho.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T02:30:54Z","timestamp":1455676254000},"page":"850-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Prognostic and Predictive Effect of TP53 Mutations in\u00a0Patients with Non\u2013Small Cell Lung Cancer from Adjuvant Cisplatin\u2013Based Therapy Randomized Trials:\u00a0A LACE-Bio Pooled Analysis"],"prefix":"10.1016","volume":"11","author":[{"given":"Xiaoli","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9na\u00ebl","family":"Le Teuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lacas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Sound","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Douillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Le Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Filipits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pirker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi A.","family":"J\u00e4nne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances A.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2016.02.002_bib1","doi-asserted-by":"crossref","first-page":"D652","DOI":"10.1093\/nar\/gkp995","article-title":"COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer","volume":"38","author":"Forbes","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtho.2016.02.002_bib2","unstructured":"Wellcome Trust Sanger Institute, Genome Research Limited. Catalogue of somatic mutations in cancer. http:\/\/cancer.sanger.ac.uk\/cancergenome\/projects\/cosmic\/. Accessed March 1, 2015."},{"key":"10.1016\/j.jtho.2016.02.002_bib3","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2016.02.002_bib4","doi-asserted-by":"crossref","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jtho.2016.02.002_bib5","doi-asserted-by":"crossref","first-page":"a001016","DOI":"10.1101\/cshperspect.a001016","article-title":"Clinical outcomes and correlates of TP53 mutations and cancer","volume":"2","author":"Robles","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jtho.2016.02.002_bib6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jtcvs.2007.10.072","article-title":"Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer","volume":"135","author":"Kandioler","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2016.02.002_bib7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbrc.2005.03.192","article-title":"The role of p53 in treatment responses of lung cancer","volume":"331","author":"Viktorsson","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtho.2016.02.002_bib8","first-page":"553","article-title":"Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer","volume":"12","author":"Huang","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1183\/09031936.00097311","article-title":"Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort","volume":"40","author":"Scoccianti","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtho.2016.02.002_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1200\/JCO.2001.19.2.448","article-title":"Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy","volume":"19","author":"Schiller","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib11","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1200\/JCO.2007.12.6953","article-title":"Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer","volume":"25","author":"Tsao","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.molonc.2013.12.015","article-title":"Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer","volume":"8","author":"Ma","year":"2014","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib13","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant\u00a0cisplatin evaluation: a pooled analysis by the\u00a0LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2016.02.002_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1200\/JCO.2009.23.2272","article-title":"Long-term results of the international adjuvant lung cancer trial\u00a0evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer","volume":"28","author":"Arriagada","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1200\/JCO.2009.24.0333","article-title":"Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10","volume":"28","author":"Butts","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib18","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2016.02.002_bib19","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in\u00a0stage IB non-small-cell lung cancer: CALGB 9633 with\u00a0the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib20","unstructured":"Travis WD, Brambilla E, M\u00fcller-Hermeking K, Harris CC, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France:\u00a02004."},{"key":"10.1016\/j.jtho.2016.02.002_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0031-1272866","article-title":"Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing","volume":"32","author":"Travis","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jtho.2016.02.002_bib22","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/annonc\/mdr624","article-title":"Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not\u00a0adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses","volume":"23","author":"Pierceall","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib23","series-title":"AJCC Cancer Staging Manual","year":"2002"},{"key":"10.1016\/j.jtho.2016.02.002_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: news\u00a0from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtho.2016.02.002_bib25","article-title":"A\u00a0genomics-based classification of human lung tumors","volume":"5","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtho.2016.02.002_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CCO.0b013e3283412dfa","article-title":"Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes","volume":"23","author":"Olivier","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jtho.2016.02.002_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtho.2016.02.002_bib28","doi-asserted-by":"crossref","first-page":"a000919","DOI":"10.1101\/cshperspect.a000919","article-title":"The tumor suppressor p53: from structures to drug discovery","volume":"2","author":"Joerger","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jtho.2016.02.002_bib29","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/cdd.2011.81","article-title":"p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53","volume":"18","author":"Melino","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jtho.2016.02.002_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4161\/pri.27776","article-title":"The aggregation of mutant p53 produces prion-like properties in cancer","volume":"8","author":"Rangel","year":"2014","journal-title":"Prion"},{"key":"10.1016\/j.jtho.2016.02.002_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nchembio.546","article-title":"Gain of function of mutant p53 by coaggregation with multiple tumor suppressors","volume":"7","author":"Xu","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jtho.2016.02.002_bib32","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/01.LAB.0000032380.82232.67","article-title":"Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63","volume":"82","author":"Chilosi","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtho.2016.02.002_bib33","doi-asserted-by":"crossref","first-page":"e5623","DOI":"10.1371\/journal.pone.0005623","article-title":"An active role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate","volume":"4","author":"Romano","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2016.02.002_bib34","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.201102-0218OC","article-title":"DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer","volume":"184","author":"van Boerdonk","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtho.2016.02.002_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","article-title":"Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway","volume":"148","author":"Freed-Pastor","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jtho.2016.02.002_bib36","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.molcel.2014.04.024","article-title":"Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation","volume":"4","author":"Zhou","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtho.2016.02.002_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1947601912462719","article-title":"Gain-of-function activity of mutant p53 in lung cancer through up-regulation of receptor protein tyrosine kinase Axl","volume":"3","author":"Vaughan","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jtho.2016.02.002_bib38","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1038\/sj.onc.1205803","article-title":"Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers","volume":"21","author":"Pfeifer","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2016.02.002_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/carcin\/22.3.367","article-title":"Patterns of p53 G\u2192T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke","volume":"22","author":"Hainaut","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtho.2016.02.002_bib40","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1158\/0008-5472.CAN-05-0551","article-title":"TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers","volume":"65","author":"Le Calvez","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2016.02.002_bib41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2012.08.024","article-title":"Genomic landscape of non-small cell lung cancer in smokers and never-smokers","volume":"150","author":"Govindan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jtho.2016.02.002_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2016.02.002_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005723","article-title":"Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers","volume":"5","author":"Rousseaux","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtho.2016.02.002_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ijc.28684","article-title":"Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive\u00a0pulmonary disease","volume":"135","author":"Sato","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtho.2016.02.002_bib45","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/pr400998n","article-title":"Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer","volume":"13","author":"Sundar","year":"2014","journal-title":"J\u00a0Proteome Res"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086416003592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086416003592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T17:19:56Z","timestamp":1668791996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086416003592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1556086416003592"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2016.02.002","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic and Predictive Effect of TP53 Mutations in\u00a0Patients with Non\u2013Small Cell Lung Cancer from Adjuvant Cisplatin\u2013Based Therapy Randomized Trials:\u00a0A LACE-Bio Pooled Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}